Literature DB >> 9160441

Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.

P Dolan1, M Sutton.   

Abstract

Despite becoming increasingly common in evaluations of health care, different methods of quantitatively measuring health status appear to produce different valuations for identical descriptions of health. This paper reports on a study that elicited health state valuations from the general public using three different methods: the visual analogue scale (VAS), the standard gamble (SG) and the time trade-off (TTO). Two variants of the SG and TTO were tested: Props (using specially designed boards and cards); and No Props (using a self-completion booklet). This paper focuses on empirical relationships between health state valuations from the VAS and the (four) other methods. The relationships were estimated using Tobit regression of individual-level data. In contrast to a priori expectations, the mapping functions estimated suggest that differences are more pronounced across variant than across method. Furthermore, relationships with VAS scores are found to depend on the severity of the state: TTO Props valuations are higher than VAS responses for mild states and lower for more severe states; SG Props valuations are broadly similar to VAS scores over a wide range; and No Props responses are consistently higher than VAS valuations, particularly for more severe states. Explanations are proposed for these findings.

Mesh:

Year:  1997        PMID: 9160441     DOI: 10.1016/s0277-9536(96)00271-7

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  26 in total

Review 1.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

2.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

3.  The precision of health state valuation by members of the general public using the standard gamble.

Authors:  Ken Stein; Matthew Dyer; Ruairidh Milne; Alison Round; Julie Ratcliffe; John Brazier
Journal:  Qual Life Res       Date:  2009-03-03       Impact factor: 4.147

4.  No decline in high patient satisfaction after total hip arthroplasty at long-term follow-up.

Authors:  P P Schmitz; J L C van Susante; A Hol; R Brokelman; C J M van Loon
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-06-01

Review 5.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Low conversion rates toward total hip arthroplasty after hemiarthroplasty in patients under 75 years of age.

Authors:  P P Schmitz; J L C van Susante; M P Somford
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-19

7.  Mapping of the OAB-SF Questionnaire onto EQ-5D in Spanish Patients with Overactive Bladder.

Authors:  Miguel A Ruiz; Laura L Gutiérrez; Manuel Monroy; Javier Rejas
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

8.  Anterior cervical discectomy with fusion in patients with cervical disc degeneration: a prospective outcome study of 258 patients (181 fused with autologous bone graft and 77 fused with a PEEK cage).

Authors:  Bjarne Lied; Paal Andre Roenning; Jarle Sundseth; Eirik Helseth
Journal:  BMC Surg       Date:  2010-03-21       Impact factor: 2.102

Review 9.  An updated systematic review of Health State Utility Values for osteoporosis related conditions.

Authors:  T Peasgood; K Herrmann; J A Kanis; J E Brazier
Journal:  Osteoporos Int       Date:  2009-03-07       Impact factor: 4.507

10.  Secondary patella resurfacing in painful non-resurfaced total knee arthroplasties : A study of survival and clinical outcome from the Norwegian Arthroplasty Register (1994-2011).

Authors:  Tesfaye H Leta; Stein Håkon L Lygre; Arne Skredderstuen; Geir Hallan; Jan-Erik Gjertsen; Berit Rokne; Ove Furnes
Journal:  Int Orthop       Date:  2015-10-23       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.